Redcliffe Labs secures $42 million in a Series C funding

The additional capital will be used to support Redcliffe’s expansion strategies

Redcliffe Labs, an omnichannel diagnostics service provider, has secured $42 million in a Series C funding round. IFU, an investment firm based in Denmark, led the round, contributing $20 million.

LeapFrog, an existing investor, contributed $15 million, while HealthQuad and Spark Growth Ventures, shareholders, contributed the remaining capital.

The additional capital will be used to support Redcliffe’s expansion strategies, with a particular emphasis on the establishment of a stronger presence in tier II and III cities throughout India.